Microfluidic platform for single nucleotide polymorphism genotyping of the thiopurine S-methyltransferase gene to evaluate risk for adverse drug events.

Prospective clinical pharmacogenetic testing of the thiopurine S-methyltransferase gene remains to be realized despite the large body of evidence demonstrating clinical benefit for the patient and cost effectiveness for health care systems. We describe an entirely microchip-based method to genotype for common single nucleotide polymorphisms in the thiopurine S-methyltransferase gene that lead to serious adverse drug reactions for patients undergoing thiopurine therapy. Restriction fragment length polymorphism and allele-specific polymerase chain reaction have been adapted to a microfluidic chip-based polymerase chain reaction and capillary electrophoresis platform to genotype the common *2, *3A, and *3C functional alleles. In total, 80 patients being treated with thiopurines were genotyped, with 100% concordance between microchip and conventional methods. This is the first report of single nucleotide polymorphism detection using portable instrumentation and represents a significant step toward miniaturized for personalized treatment and automated point-of-care testing.

[1]  Govind V Kaigala,et al.  Automated screening using microfluidic chip‐based PCR and product detection to assess risk of BK virus‐associated nephropathy in renal transplant recipients , 2006, Electrophoresis.

[2]  G. Whitesides.  The origins and the future of microfluidics , 2006, Nature.

[3]  Wen-Tso Liu,et al.  Miniaturized platforms for the detection of single-nucleotide polymorphisms , 2006, Analytical and bioanalytical chemistry.

[4]  R. Weinshilboum,et al.  Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions , 2006, Oncogene.

[5]  N. Reynolds,et al.  Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial , 2006, The Lancet.

[6]  Stephen R Quake,et al.  Parallel picoliter rt-PCR assays using microfluidics. , 2006, Analytical chemistry.

[7]  Brian N. Johnson,et al.  An integrated microfluidic device for influenza and other genetic analyses. , 2005, Lab on a chip.

[8]  Jürgen Brockmöller,et al.  Pharmacogenetics-based therapeutic recommendations — ready for clinical practice? , 2005, Nature Reviews Drug Discovery.

[9]  Christopher J. Backhouse,et al.  On-chip HA/SSCP for the detection of hereditary haemochromatosis , 2005 .

[10]  Ruifang Zhang,et al.  SNP Cutter: a comprehensive tool for SNP PCR–RFLP assay design , 2005, Nucleic Acids Res..

[11]  James P Landers,et al.  Advances in polymerase chain reaction on microfluidic chips. , 2005, Analytical chemistry.

[12]  Xuezhu Liu,et al.  Electrokinetically based approach for single-nucleotide polymorphism discrimination using a microfluidic device. , 2005, Analytical chemistry.

[13]  Michael Christiansen,et al.  High‐throughput single‐strand conformation polymorphism analysis on a microfabricated capillary array electrophoresis device , 2005, Electrophoresis.

[14]  Christopher J Backhouse,et al.  Integration of combined heteroduplex/restriction fragment length polymorphism analysis on an electrophoresis microchip for the detection of hereditary haemochromatosis. , 2004, The Analyst.

[15]  K. Kaler,et al.  An integrated method for mutation detection using on‐chip sample preparation, single‐stranded conformation polymorphism, and heteroduplex analysis , 2004, Electrophoresis.

[16]  S. Mascheretti,et al.  Pharmacogenetics of inflammatory bowel disease. , 2004, Best practice & research. Clinical gastroenterology.

[17]  W. Evans.  Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine Therapy , 2004, Therapeutic drug monitoring.

[18]  C. Peterson,et al.  Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. , 2004, Clinical chemistry.

[19]  Elisabeth Verpoorte,et al.  Beads and chips: new recipes for analysis. , 2003, Lab on a chip.

[20]  Min-Yuan Wu,et al.  [Exploration of methodology for assay of single nucleotide polymorphism in thiopurine methyltransferase gene]. , 2003, Zhongguo shi yan xue ye xue za zhi.

[21]  L. Becquemont.  Clinical Relevance of Pharmacogenetics , 2003, Drug metabolism reviews.

[22]  H. John Crabtree,et al.  Sample purification on a microfluidic device , 2001, Electrophoresis.

[23]  M Pirmohamed,et al.  Genetic susceptibility to adverse drug reactions. , 2001, Trends in pharmacological sciences.

[24]  M. Eichelbaum,et al.  High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC. , 2001, Clinical chemistry.

[25]  Igor L. Medintz,et al.  High-performance multiplex SNP analysis of three hemochromatosis-related mutations with capillary array electrophoresis microplates. , 2001, Genome research.

[26]  J P Landers,et al.  Capillary and microchip electrophoresis for rapid detection of known mutations by combining allele-specific DNA amplification with heteroduplex analysis. , 2001, Clinical chemistry.

[27]  J P Landers,et al.  Rapid detection of deletion, insertion, and substitution mutations via heteroduplex analysis using capillary- and microchip-based electrophoresis. , 2000, Genome research.

[28]  N. Risch.  Searching for genetic determinants in the new millennium , 2000, Nature.

[29]  Rolf Hilfiker,et al.  The use of single-nucleotide polymorphism maps in pharmacogenomics , 2000, Nature Biotechnology.

[30]  W. Evans,et al.  Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia , 2000, Leukemia.

[31]  G. Whitesides,et al.  Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). , 1998, Analytical chemistry.

[32]  B K Tang,et al.  Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research. , 1998, Pharmacogenetics.

[33]  R. Weinshilboum,et al.  Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms , 1997, Clinical pharmacology and therapeutics.

[34]  W. Evans,et al.  Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Ching-Hon Pui,et al.  Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance , 1997, Annals of Internal Medicine.

[36]  J. Lilleyman,et al.  Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia. , 1993, Archives of disease in childhood.

[37]  W. Evans,et al.  Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. , 1991, The Journal of pediatrics.

[38]  R. Weinshilboum,et al.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. , 1980, American journal of human genetics.

[39]  C. Eap,et al.  Therapeutic Drug Monitoring and Pharmacogenetic Tests as Tools in Pharmacovigilance , 2006, Drug safety.

[40]  M. Hopkins,et al.  The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies , 2006, The Pharmacogenomics Journal.

[41]  Arul M. Chinnaiyan,et al.  VISION: Oncomine and cabig advance cancer bioinformatics , 2005 .

[42]  L. Lennard,et al.  Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine. , 2004, Rheumatology.

[43]  M. Somerville,et al.  Heteroduplex-based genotyping with microchip electrophoresis and dHPLC. , 2003, Genetic testing.

[44]  P. Sullivan,et al.  Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput , 2003, The Pharmacogenomics Journal.

[45]  P. Beaune,et al.  Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients. , 2001, Journal of the American Society of Nephrology : JASN.

[46]  V. Neuhoff.  Microelectrophoresis and auxilary micromethods , 2000, Electrophoresis.

[47]  D. Marez,et al.  Detection of known and new mutations in the thiopurine S‐methyltransferase gene by single‐strand conformation polymorphism analysis , 1998, Human mutation.

[48]  G. Ramsay.  DNA chips: State-of-the art , 1998, Nature Biotechnology.

[49]  W. W. Nichols,et al.  A sensitive restriction fragment length polymorphism method to detect CAA → AAA mutations at codon 61 of Ha‐ras , 1993, Molecular carcinogenesis.